Selecting the correct vendors to support your UX project is critical to success. From facilities to recruiting, knowing the right questions to ask, budget constraints, and client needs and expectations will make the selection process smooth and painless.
Back to team page
Jim Kershner
Director
Jim has 20+ years of medical device product development experience, ranging from orthopedic implants and surgical instruments, to endovascular products, to drug delivery systems. Jim conducts and manages both UX and human factors projects in the healthcare space. Jim has a BS in Physics from Appalachian State University and an MEngSc in Biomedical Engineering from the University of New South Wales.



Bold facts
Learn more about

Something unique about you summed up in one sentence:

Your favorite part of working at Bold Insight

In your spare time (or if you had spare time), you would absolutely do this:

Long-term personal or professional goal?

How long have you been in the UX field?

Your ultimate celebrity dinner party guest list would include:

Your favorite city in the world is...and why?

Any other facts to share?
- Bold Insight presents with Stryker, Genentech, and AbbVie at the HFES Healthcare Symposium
- Human factors optimization: How to leverage HF researchers in your medtech team
- Bold Insight featured in Packaging Digest on when to finalize design elements of your medical device packaging
- What medtech design teams need to know about AI regulations
- 3 crucial aspects of submitting a successful human factors engineering package to the FDA
- Bold Insight to present on IFU design, digital telemetry, and other human factors topics at HFES Healthcare Symposium
Read our team’s latest bold insights
Reclassifying diabetes: 3 implications for product design
Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.
Designing your POS so it’s not a POS
Regardless of whether the interface is intended to be used by a customer (novice) or an employee (expert), the key is to ensure that the POS interface is designed for the intended audience. To do this, organizations should engage users throughout the design process.
FDA’s digital health precertification program emphasizes importance of post-market surveillance
Finding efficient ways to leverage post-market surveillance data to inform product development at an institutional level will be key for SaMD manufacturers seeking FDA precertification.